Concurrent Investment Advisors LLC Purchases 95 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Concurrent Investment Advisors LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 877 shares of the biotechnology company’s stock after buying an additional 95 shares during the period. Concurrent Investment Advisors LLC’s holdings in Axon Enterprise were worth $521,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Geode Capital Management LLC boosted its holdings in shares of Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares during the period. Westfield Capital Management Co. LP raised its stake in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC raised its stake in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise during the 3rd quarter valued at $200,000. 79.08% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares in the company, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock worth $5,631,561 in the last quarter. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Trading Down 2.6 %

Shares of Axon Enterprise stock opened at $499.73 on Tuesday. The stock has a market capitalization of $38.11 billion, a P/E ratio of 129.13, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a 50-day simple moving average of $616.95 and a 200 day simple moving average of $520.78. Axon Enterprise, Inc. has a 12-month low of $265.32 and a 12-month high of $715.99.

Analyst Ratings Changes

Several research firms recently commented on AXON. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research note on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.